ANNA MANDALAKAS to Microbial Sensitivity Tests
This is a "connection" page, showing publications ANNA MANDALAKAS has written about Microbial Sensitivity Tests.
Connection Strength
0.142
-
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement. Lancet Infect Dis. 2023 04; 23(4):e122-e137.
Score: 0.040
-
Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children. Cochrane Database Syst Rev. 2022 09 06; 9:CD013359.
Score: 0.039
-
Management of drug-resistant tuberculosis. Lancet. 2019 09 14; 394(10202):953-966.
Score: 0.032
-
Management of patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2019 06 01; 23(6):645-662.
Score: 0.031